Telix Pharmaceuticals Limited ( TLPPF) - Stock Earnings
TLPPF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -3.5 million USD | 593.1 million USD |
| 2025Q4 | -7.4 million USD | 630.7 million USD |
| 2026Q2 | 54.5 million USD | 678.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q2 Est. | — | — |
TLPPF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.2 million USD | 502.5 million USD |
| 2024 | 49.9 million USD | 783.2 million USD |
| 2025 | -11.0 million USD | 1.2 billion USD |
| 2026 Est. | — | — |
TLPPF
Price: $10.24
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 113.70
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.6 billion